One in seven people experience migraine’s disabling reach. Millions more, including me, endure other headache disorders. I ...
Mirum Pharmaceuticals (($MIRM)) announced an update on their ongoing clinical study. Study Overview: Mirum Pharmaceuticals is conducting a Phase 2 ...
TipRanks on MSN
Pfizer’s New Migraine Treatment: A Promising Phase 3 Study
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has initiated a Phase 3 clinical study titled ‘An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback